1196-92-5
1196-92-5
Chemical Structure
Vanillylamine
- CAS No.: 1196-92-5
- Formula:C8H11NO2
- Molecular Weight:153.18
IUPAC Name: 4-(aminomethyl)-2-methoxyphenol
InChIKey: WRPWWVNUCXQDQV-UHFFFAOYSA-N
SMILES: COC1=C(C=CC(=C1)CN)O
Biological Activity: Vanillylamine is an immediate precursor for capsaicinoids. Vanillylamine is a derivative of Vanillin (HY-N0098) is synthesized through a transaminase reaction in the phenylpropanoid pathway of capsaicinoid synthesis. Vanillylamine significantly alleviates myelosuppression caused by abdominal and pelvic tumor chemotherapy[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Vanillylamine | 98.05% | Vanillylamine is an immediate precursor for capsaicinoids. Vanillylamine is a derivative of Vanillin (HY-N0098) is synthesized through a transaminase reaction in the phenylpropanoid pathway of capsaicinoid synthesis. Vanillylamine significantly alleviates myelosuppression caused by abdominal and pelvic tumor chemotherapy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Vanillylamine (Standard) | ≥98% | Vanillylamine is an immediate precursor for capsaicinoids. Vanillylamine is a derivative of Vanillin (HY-N0098) is synthesized through a transaminase reaction in the phenylpropanoid pathway of capsaicinoid synthesis. Vanillylamine significantly alleviates myelosuppression caused by abdominal and pelvic tumor chemotherapy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Harishchandra B Gururaj, et al. Functional validation of Capsicum frutescens aminotransferase gene involved in vanillylamine biosynthesis using Agrobacterium mediated genetic transformation studies in Nicotiana tabacum and Capsicum frutescens calli cultur [Content Brief]
- [2]. Zhenhui Chen, et al. The Gut Microbiota Lachnospiraceae and Its Bacterial Metabolite Vanillylamine Significantly Alleviate Myelosuppression Caused By Abdominal and Pelvic Tumor Chemotherapy. Blood. Volume 144, Supplement 1, 5 November 2024, Page 5671.
